Candriam SCA’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-212,665
Closed -$5.79M 700
2023
Q4
$5.79M Buy
212,665
+83,000
+64% +$2.06M 0.04% 324
2023
Q3
$3.12M Hold
129,665
0.02% 374
2023
Q2
$4.14M Buy
129,665
+50,000
+63% +$1.62M 0.03% 367
2023
Q1
$2.25M Hold
79,665
0.02% 554
2022
Q4
$3.12M Hold
79,665
0.02% 492
2022
Q3
$3.79M Hold
79,665
0.03% 444
2022
Q2
$3.08M Buy
79,665
+2,518
+3% +$100K 0.03% 406
2022
Q1
$4.42M Hold
77,147
0.03% 374
2021
Q4
$6.15M Hold
77,147
0.04% 319
2021
Q3
$6.71M Hold
77,147
0.05% 335
2021
Q2
$9.93M Buy
+77,147
New +$6.15M 0.07% 286

Other funds holding BEAM